新型冠状病毒肺炎疫情期间慢性阻塞性肺疾病医疗和防范须知

Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic

目前,新型冠状病毒肺炎(简称新冠肺炎)在我国的疫情形势较为严峻,并有席卷全球的趋势。流行病学资料显示:老年以及合并慢性基础疾病是重症、危重症的高危人群;合并慢性阻塞性肺疾病(慢阻肺)的患者具有较高的病死率。我国有近1亿例的慢阻肺患者,大多为老年人,一旦感染新冠肺炎,将给患者造成极大的生命威胁。因此,在疫情期间,需要高度重视对慢阻肺患者进行规范的诊疗及防范。中华医学会呼吸病学分会慢阻肺学组、中国医师协会呼吸医师分会慢阻肺工作委员会共同起草了新冠肺炎疫情期间慢阻肺医疗和防范须知,供相关医务人员以及患者参考。

Currently,coronavirus disease 2019(COVID-19)was of clustering onset in China and challenging the Chinese healthcare system.Epidemiological data showed that older patients with chronic diseases were at high risk of the involvement of the severe and critical type of COVID-19,especially patients with chronic obstructive pulmonary disease(COPD)resulting in high mortalities.There were nearly 100 million COPD patients in China,and most of them were elderly.Once infected with COVID-19,it would be life-threatening for the COPD patients.Therefore,during the epidemic,it was of vital significance for us to attach great importance to optimize the management of COPD patients.Based on these considerations,the COPD Group of the Chinese Thoracic Society(CTS)and the COPD working Committee of the Chinese Association of Chest Physicians(CACP)altogether drafted the instruction for medical management and prevention of COPD during the COVID-19 epidemic period for the healthcare practitioner and patients.